Our Business Focus

Three decades ago engineers realized that fabrication methods that gave birth to the semiconductor industry could be used to make devices for regulating nano-scale quantities of fluids and gasses. That is, a variation on photo lithography could be used to finely pattern chips having microscopic channels, pumps, valves, and other components. These components could be densely arrayed for parallel operations, without loss of reliability.

Fluidigm is making that vision a reality through the introduction of integrated fluidic circuits (IFCs). Our mission is to develop, manufacture, and distribute systems composed of IFCs, instrumentation, and consumables, enabling new efficiencies in science and industry. The Company's product pipeline includes the TOPAZ® system for protein crystallization, introduced in 2002, and the BioMark™ system for genetic analysis, launched in December 2006. Fluidigm exercises a core competence in materials science and IFC fabrication. The Company's patent portfolio consists of over 25 issued US patents and over 200 pending patents internationally, including those licensed from Caltech, Harvard, and the University of Alabama.

Company Highlights

1999
- Founding of Fluidigm Corporation (originally Mycometrix) to
commercialize IFC technology developed in the laboratory of biophysicist Stephen Quake, PhD.
2003
- Launch of the TOPAZ® System for Protein Crystallization, including IFCs that assemble 768 crystallization conditions in parallel and instrumentation and software that automate the digital imaging and analysis of crystals.
2004
- Development of IP around a new class of IFCs referred to as dynamic arrays and of prototypes yielding as many as 9,216 parallel data points.
2005
- Opening of a 15,000 square-foot IFC fabrication facility in Singapore.
2006
- Launch of the BioMark® Real-Time PCR System, a multi-application hardware/software platform based on BioMark dynamic arrays, which require only 96 liquid-transfer steps to assemble 2,304 reactions.
- Introduction of BioMark digital arrays, heralded as the only practical solution for ultra-sensitive detection by digital PCR.
2007
- Launch of high-throughput genotyping on the BioMark system, a breakthrough for the study of genetic variation within large populations.

© Fluidigm Corporation. All rights reserved.
Fluidigm Corporation | 7000 Shoreline Court, Suite 100 | South San Francisco, CA 94080
Phone:(650)266-6000 Fax:(650)871-7152
Legal Information